ヘルスケアチャットボットの世界市場-2024～2031年

概要

医療チャットボットの世界市場は、2023年に6億8,066万米ドルに達し、2031年には34億8,866万米ドルに達すると予測され、予測期間2024～2031年のCAGRは22.9%で成長すると予測されています。

医療チャットボットとしても知られる医療用チャットボットは、医療をよりインタラクティブかつプロアクティブにするために設計されたAI搭載の会話型ソリューションです。これらのチャットボットは、医療スタッフが患者情報の収集と処理、医療関連ガイドラインの周知、患者エンゲージメントの確保などに費やす時間を大幅に削減することで、医療システムの貴重な資産として機能します。

医療チャットボットは、患者と医療提供者の橋渡し役として、多くの場合、クリニックや病院、その他の医療機関との最初の接点となります。24時間365日、指先一つで医療サポートが受けられ、パーソナライズされ、効率的な世界を想像してみてください。このシナリオは遠い未来の話ではなく、医療チャットボットの登場によって現在の現実となりました。これらのAIを搭載したバーチャルアシスタントは、医療プロバイダーが患者と対話し、データを管理し、業務を最適化する方法を変革しています。

AI、神経合成AI、自然言語処理（NLP）を搭載した医療チャットボットは、患者ケアと管理効率に革命をもたらしています。予約リマインダーの設定、書類提出の促進、継続的な患者サポートなどのタスクを支援します。医療チャットボットの領域を探求することで、医療チャットボットがいかに即時的なデジタル医療対話の需要に応えるだけでなく、医療産業全体を強化する重要な役割を担っているかがわかると考えられます。これらの要因が医療チャットボットの世界市場拡大の原動力となっています。

市場力学：

促進要因と阻害要因

バーチャル医療アシスタンス需要の増加

バーチャル医療アシスタンスへの需要の高まりは、世界の医療チャットボット市場の成長を大きく牽引しており、市場予測期間中も牽引していくと予測されています。

医療提供に対する消費者の意識に著しい変化が生じています。2024年10月のTechTargetのデータによると、バーチャル医療サービスを利用したことのある消費者の94％が、こうした選択肢を継続して利用する意向を示しています。この変化は特に若い層で顕著で、ミレニアル世代の43％、ジェネレーションZの33％が、改善されたバーチャル受診オプションのために医療プロバイダーを変更する用意があると表明しています。この動向は、バーチャル医療サービスが提供する利便性とアクセシビリティに対する強い嗜好を示しています。

パンデミックはバーチャル医療ソリューションの採用を大幅に加速させました。2022年5月の米国生物工学情報センター（NCBI）のデータによると、遠隔医療の利用が急増し、パンデミック前の水準と比較して遠隔医療による診察が230％以上増加したとの報告があります。患者がバーチャル診察の利点を体験するにつれ、多くの患者が従来の対面診察に代わる実用的な方法であることに気づいた。移動の制限が緩和された現在でも、遠隔医療サービスに対する需要は依然として高く、このシフトが永続的なものである可能性を示唆しています。

バーチャル医療サービスは、患者と医療提供者の双方にとって費用対効果が高いです。患者は交通費と仕事を離れる時間を節約でき、医療提供者は物理的なオフィススペースに関連する諸経費を削減できます。さらに、バーチャル医療は、特に医療施設が限られているような地方や十分なサービスを受けていない地域における、医療へのアクセスのギャップを埋めるのに役立ちます。

AIチャットボットのような先進技術の統合は、患者からの問い合わせに即座に回答し、予約のスケジューリングを容易にし、症状評価を提供することで、バーチャル医療サービスの有効性を高めています。これらの技術は、患者のエンゲージメントを向上させ、管理プロセスを合理化し、バーチャルケアをより効率的にします。これらすべての要因が、世界の医療チャットボット市場に需要をもたらしています。

さらに、パートナーシップやコラボレーションなどの主要企業の戦略は、この世界の医療チャットボット市場の成長を促進すると考えられます。例えば、2024年7月、GE HealthcareとAmazon Web Services（AWS）の提携は、特に診断プロセスの強化という観点から、医療セグメントにおける人工知能（AI）の統合における重要な進歩を示しています。この提携は、チャットボットを含むAI技術を活用し、患者ケアと臨床的意思決定を向上させるという増加傾向に沿った極めて重要なものです。

また、2024年9月、Hackensack Meridian HealthとK Healthが提携し、HMH 24/7バーチャルプライマリケアサービスを開始することは、世界の医療チャットボット市場において重要な進展です。このイニシアチブは、医療、特にデジタルプラットフォームを通じてプライマリケアへのアクセスを改善するためのAI駆動型ソリューションの統合が増加していることを強調しています。これらすべての要因が、世界の医療チャットボット市場に需要をもたらしています。

さらに、人工知能の進歩に対する需要の高まりも、世界の医療チャットボット市場の拡大に寄与しています。

データプライバシーに関する懸念

データプライバシーに関する懸念は、医療チャットボットの世界市場における重要な抑制要因であり、これらの技術の採用や導入に影響を与えています。医療チャットボットが普及するにつれ、機密性の高い患者情報の管理は、セキュリティ、コンプライアンス、信頼性に関わる重要な問題を引き起こしています。

医療データは、個人情報の中でも最もセンシティブなものです。これには、病歴、治療計画、特定可能な医療情報（PHI）などの詳細が含まれます。このデータの不正な開示や誤った取り扱いは、個人情報の盗難、差別、患者の信頼の喪失など、深刻な結果を招く可能性があります。チャットボットは、パーソナライズされたサービスを提供するために、この機密データへのアクセスを必要とすることが多いため、その保護の確保は極めて重要です。

2023年11月に発表された米国立生物工学情報センター（NCBI）の調査発表によると、AIチャットボットの使用には膨大な量の個人データの収集と保存が必要であり、データセキュリティとプライバシーに関する重大な懸念が生じる。AIモデルの効果的な運用は、継続的な機械学習に依存しており、これは、これらのチャットボットのニューラルネットワークに大規模なデータセットを一貫して入力し直すことを含みます。チャットボットを訓練するために使用されるデータに機密性の高い患者情報やビジネス情報が含まれている場合、それは将来の対話で利用されるデータセットの一部となります。その結果、このデータは意図した対象者にも意図しない対象者にも開示される可能性があり、適切な承認なしにさまざまな目的に使用される可能性があります。

AIチャットボットには限られた能力しかないという認識にもかかわらず、チャットボットはユーザーの反応を捉えながら多様なデータソースから新たな情報を収集・収集する大きな可能性を秘めています。より多くのデータが収集され、インターネット上で広く共有されるにつれて、データのセキュリティと機密性の確保はますます困難になっています。情報量の増大は、機密データを不正アクセスや悪用から保護することの難しさを高めています。

さらに、AIチャットボットは、そのインタラクションを通じて機密情報を不注意に暴露する可能性があります。例えば、ユーザーがチャットボットに健康上の機密事項や独自のビジネス情報を入力した場合、このデータが保存され、後に不正アクセスされるリスクがあります。このような状況は、個人情報を保護し、これらの技術に対するユーザーの信頼を維持するための厳格なセキュリティ対策の必要性を強調しています。したがって、上記の要因が世界の医療チャットボット市場の潜在的な成長を制限している可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • バーチャル健康支援の需要増加
  • 抑制要因
    • データプライバシーに関する懸念
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 特許分析
• 規制分析
• SWOT分析
• アンメットニーズ

第6章 コンポーネント別

• ソフトウェア
• サービス

第7章 展開別

• クラウド
• オンプレミス

第8章 用途別

• 症状の確認
• 予約スケジュールとモニタリング
• 医療と医薬品情報支援
• その他

第9章 エンドユーザー別

• 患者
• 保険会社
• 医療提供者
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他の欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• Your.MD Ltd.
• HealthTap, Inc.
• Sensely, Inc.
• Buoy Health, Inc.
• Infermedica
• Ada Health GmbH
• PACT Care BV.
• Woebot Health
• GYANT
• Kenyt Inc.

第13章 付録

Overview

The global healthcare chatbots market reached US$ 680.66 million in 2023 and is expected to reach US$ 3,488.66 million by 2031, growing at a CAGR of 22.9% during the forecast period 2024-2031.

A medical chatbots, also known as healthcare chatbots, is an AI-powered conversational solution designed to make healthcare more interactive and proactive. These chatbots serve as valuable assets to the healthcare system by significantly reducing the time medical staff spend on collecting and processing patient information, disseminating healthcare-related guidelines, ensuring patient engagement, and more.

Healthcare chatbots act as a bridge between patients and their healthcare providers, often serving as the first point of contact with clinics, hospitals, or other healthcare organizations. Imagine a world where healthcare support is available 24/7 at your fingertips, personalized and efficient. This scenario is not a distant future but a current reality, to the emergence of healthcare chatbots. These AI-powered virtual assistants are transforming how healthcare providers interact with patients, manage data, and optimize operations.

Equipped with AI, neuro-synthetic AI, and natural language processing (NLP), healthcare chatbots are revolutionizing patient care and administrative efficiency. They assist with tasks such as setting appointment reminders, facilitating document submissions, and providing continuous patient support. By exploring the realm of healthcare chatbots, we will see how they not only meet the demand for immediate digital healthcare interactions but also play a significant role in enhancing the overall healthcare industry. These factors have driven the global healthcare chatbots market expansion.

Market Dynamics: Drivers & Restraints

Increasing Demand for Virtual Health Assistance

The increasing demand for virtual health assistance is significantly driving the growth of the global healthcare chatbots market and is expected to drive throughout the market forecast period.

There has been a marked change in consumer attitudes towards healthcare delivery. According to the TechTarget data in October 2024, indicate that 94% of consumers who have utilized virtual health services are willing to continue using these options. This shift is especially pronounced among younger demographics, with 43% of millennials and 33% of Generation Z expressing readiness to switch healthcare providers for improved virtual visit options. This trend underscores a strong preference for the convenience and accessibility that virtual health services provide.

The pandemic significantly accelerated the adoption of virtual healthcare solutions. As per National Center for Biotechnology Information (NCBI) data in May 2022, telemedicine usage surged, with reports indicating increases of over 230% in telemedicine consultations compared to pre-pandemic levels. As patients experienced the benefits of virtual consultations, many found them to be a practical alternative to traditional in-person visits. Even as mobility restrictions have eased, the demand for telehealth services remains high, suggesting that this shift may be permanent.

Virtual health services can be more cost-effective for both patients and providers. Patients save on transportation costs and time away from work, while providers can reduce overhead costs associated with physical office space. Additionally, virtual health can help bridge gaps in access to care, particularly in rural or underserved areas where medical facilities may be limited.

The integration of advanced technologies such as AI chatbots enhances the effectiveness of virtual health services by providing immediate responses to patient inquiries, facilitating appointment scheduling, and offering symptom assessments. These technologies improve patient engagement and streamline administrative processes, making virtual care more efficient. All these factors demand the global healthcare chatbots market.

Furthermore, key players' strategies such as partnerships and collaborations would drive this global healthcare chatbots market growth. For instance, in July 2024, the partnership between GE HealthCare and Amazon Web Services (AWS) marks a significant advancement in the integration of artificial intelligence (AI) within the healthcare sector, particularly in the context of enhancing diagnostic processes. This collaboration is pivotal as it aligns with the growing trend of utilizing AI technologies, including chatbots, to improve patient care and clinical decision-making.

Also, in September 2024, the partnership between Hackensack Meridian Health and K Health to launch the HMH 24/7 virtual primary care service is a significant development in the global healthcare chatbot market. This initiative highlights the increasing integration of AI-driven solutions in healthcare, particularly in improving access to primary care through digital platforms. All these factors demand the global healthcare chatbots market.

Moreover, the rising demand for the advancements in artificial intelligence contributes to the global healthcare chatbots market expansion.

Data Privacy Concerns

Data privacy concerns are a significant restraint in the global healthcare chatbots market, impacting the adoption and implementation of these technologies. As healthcare chatbots become more widespread, the management of sensitive patient information raises critical issues related to security, compliance, and trustworthiness.

Healthcare data is among the most sensitive types of personal information. It includes details such as medical histories, treatment plans, and identifiable health information (PHI). Unauthorized disclosure or mishandling of this data can lead to severe consequences, including identity theft, discrimination, and loss of patient trust. Since chatbots often require access to this sensitive data to deliver personalized services, ensuring its protection is crucial.

According to the National Center for Biotechnology Information (NCBI) research publication in November 2023, the use of AI chatbots necessitates the collection and storage of vast amounts of personal data, which raises significant concerns regarding data security and privacy. The effective operation of AI models relies on continuous machine learning, which involves consistently inputting large datasets back into the neural networks of these chatbots. If the data used to train a chatbot includes sensitive patient or business information, it becomes part of the dataset utilized in future interactions. Consequently, this data could potentially be disclosed to both intended and unintended audiences and used for various purposes without proper authorization.

Despite the perception that AI chatbots have limited capabilities, they possess a substantial potential to gather and collect new information from diverse data sources while capturing user responses. As more data is collected and shared widely across the internet, ensuring data security and confidentiality becomes increasingly challenging. The growing volume of information raises the difficulty of protecting sensitive data from unauthorized access or misuse.

Moreover, AI chatbots can inadvertently expose sensitive information through their interactions. For instance, if users input confidential health details or proprietary business information into a chatbot, there is a risk that this data could be stored and later accessed by unauthorized parties. This situation emphasizes the need for stringent security measures to safeguard personal information and maintain user trust in these technologies. Thus, the above factors could be limiting the global healthcare chatbots market's potential growth.

Segment Analysis

The global healthcare chatbots market is segmented based on component, deployment, application, end-user, and region.

Component:

The software segment is expected to dominate the global healthcare chatbots market share

The software segment holds a major portion of the global healthcare chatbots market share and is expected to continue to hold a significant portion of the global healthcare chatbots market share during the forecast period.

The software segment is expected to maintain its leading position as healthcare providers increasingly recognize the value of chatbot solutions in enhancing patient engagement and streamlining operations. Healthcare chatbots software often features versatile application programming interfaces (APIs) that facilitate integration with existing healthcare systems, such as electronic health records (EHRs). This integration supports better data management and continuity of care. Many chatbot providers adopt subscription-based pricing structures, offering freemium versions that can be upgraded to premium plans. This model encourages widespread adoption while generating consistent revenue streams for developers.

The ongoing development of chatbot software is propelled by advanced technological features that enhance functionality. Natural Language Processing (NLP) This technology allows chatbots to better understand and interpret user queries, facilitating more natural and effective interactions. The ability to communicate in multiple languages increases the accessibility of chatbots, catering to diverse patient populations. With the rise in smartphone usage, chatbots are increasingly designed to function seamlessly across various mobile platforms, improving user convenience.

Furthermore, key players in the industry product launches that would drive this segment growth in the global healthcare chatbots market. For instance, in April 2023, Sensely Labs announced the integration of ChatGPT into its Front Door Navigator product. This development represents a significant enhancement in how insurance policyholders can interact with their insurance providers, enabling them to receive intuitive answers to their most pressing queries quickly and efficiently.

Also, in October 2023, the launch of ten new health chatbots represents a significant advancement in healthcare technology, aimed at improving the lives of millions by providing accessible, personalized health information and support. These chatbots leverage artificial intelligence (AI) to assist users in managing their health proactively and navigating complex healthcare systems.

Similarly, in October 2023, Mendel.ai launched a chatbot specifically aimed at helping users manage and access their medical records. This innovative tool is designed to simplify the process of retrieving health information, making it more straightforward for patients to comprehend their medical history and treatment options. By utilizing advanced AI technology, the chatbot offers personalized responses to user inquiries, thereby enhancing patient engagement and improving communication between patients and healthcare providers. These factors have solidified the segment's position in the global healthcare chatbots market.

Geographical Analysis

North America is expected to hold a significant position in the global healthcare chatbots market share

North America holds a substantial position in the global healthcare chatbots market and is expected to hold most of the market share.

The increasing demand for accessible and efficient healthcare services is a significant driver in the North American healthcare chatbots market. Patients expect immediate access to healthcare information and services, mirroring the convenience they experience in other sectors such as retail and banking. Healthcare chatbots cater to this demand by providing 24/7 availability, allowing patients to seek medical advice, schedule appointments, and receive follow-up care without delay. This capability addresses traditional barriers to healthcare access, such as office hours and geographical limitations.

By enabling patients to interact with chatbots for routine inquiries and appointment scheduling, healthcare providers can significantly reduce waiting times in clinics and hospitals. This efficiency enhances patient satisfaction and improves overall care delivery. The rapid advancement of artificial intelligence (AI) and natural language processing (NLP) technologies has made chatbots more capable of handling complex medical inquiries. These technologies allow chatbots to understand context, interpret user queries accurately, and provide personalized responses.

Furthermore, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, and product launches would propel this global healthcare chatbots market. For instance, in September 2023, HealthTap, a prominent virtual healthcare provider in the U.S., launched an enhanced version of its Dr.A.I. feature, which utilizes OpenAI's GPT-4 technology. This innovative tool is designed to streamline the patient interview process before medical appointments, enabling a more efficient and personalized healthcare experience.

Also, in September 2024, the International Myeloma Foundation (IMF) proudly launched Myelo, the first AI-powered responsive chatbot designed to serve as a virtual assistant for patients, care partners, and healthcare professionals dealing with multiple myeloma. This innovative tool aims to enhance the support and resources available to individuals affected by this complex disease.

Similarly, in April 2024, the Advanced Research Projects Agency for Health (ARPA-H) launched the Chatbot Accuracy and Reliability Evaluation (CARE) Exploration Topic (ET) to enhance the development and evaluation of chatbots used in patient-facing applications. This initiative is crucial given the increasing reliance on digital health tools, especially as more than half of American households utilize the Internet for health-related activities, including researching medical information. Thus, the above factors are consolidating the region's position as a dominant force in the global healthcare chatbots market.

Asia Pacific is growing at the fastest pace in the global healthcare chatbots market share

Asia Pacific holds the fastest pace in the global healthcare chatbots market and is expected to hold most of the market share.

The Asia-Pacific healthcare chatbots market is witnessing significant growth, primarily driven by rapid digitalization in the healthcare sector and advancements in artificial intelligence (AI) and natural language processing (NLP).

The healthcare landscape in the Asia-Pacific region is undergoing a profound transformation due to digitalization. This shift involves the adoption of digital technologies aimed at improving healthcare delivery, streamlining operations, and enhancing patient experiences. Healthcare chatbots are increasingly integrated into existing digital health platforms, enabling seamless communication between patients and providers. This integration enhances overall efficiency in healthcare delivery.

The continuous evolution of AI and NLP technologies significantly boosts the capabilities of healthcare chatbots. These advancements allow chatbots to provide more accurate and personalized health assistance, which is crucial in the diverse Asia-Pacific region. With advancements in NLP, chatbots can better comprehend and interpret complex medical inquiries. This capability enables them to respond accurately to patient questions, resulting in a more satisfying user experience.

Furthermore, in this region, key player's initiatives, key developments, and product launches would drive the global healthcare chatbots market growth. For instance, in March 2024, The Centre for Artificial Intelligence and Robotics (CAIR), part of the Chinese Academy of Sciences (CAS), developed a large language model-based chatbot specifically designed to assist doctors in making medical diagnoses and treatment decisions. This initiative reflects a growing trend in leveraging artificial intelligence to enhance healthcare delivery and improve clinical outcomes.

Also, in April 2024, Fortis Healthcare launched an AI-powered chatbot designed to assist individuals grappling with mental health challenges in India. Named "Adayu Mindfulness," the app offers psychological support akin to a first aid kit, specially tailored for those hesitant to seek professional help due to societal stigma. Stella, the AI chatbot embedded within the app, engages users in conversation and recommends self-assessment tools to help them understand their mental health status.

Similarly, in November 2024, the Ayushman Bharat Digital Mission (ABDM) launched a WhatsApp Chatbot designed to provide citizens with quick and easy access to healthcare information directly through the popular messaging platform. This initiative aims to enhance digital health guidance by making it readily available to users, thereby improving their ability to obtain essential health-related information.

Additionally, in June 2023, DocPlix launched Panini, an AI-powered chatbot specifically designed by doctors for doctors, aiming to enhance clinical practice by improving diagnostic precision, accelerating complex computations, and reducing medical judgment errors. The launch event was attended by over 250 top physicians in India, marking a significant milestone in the healthcare industry. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global healthcare chatbots market.

Competitive Landscape

The major global players in the healthcare chatbots market include Your.MD Ltd., HealthTap, Inc., Sensely, Inc., Buoy Health, Inc., Infermedica, Ada Health GmbH, PACT Care BV., Woebot Health, GYANT, and Kenyt Inc. others.

Key Developments

• In November 2024, HealthSci.AI launched a revolutionary suite of health-focused and biotech-driven chatbots designed to empower users with personalized guidance and support across a wide array of health and biotechnology topics. This initiative aims to create an accessible pathway for individuals to proactively manage their health and navigate the complexities of biotechnology with confidence.
• In January 2024, Kauvery Hospital launched Floatbot, an advanced AI-driven chatbot on its website, aimed at enhancing patient care and engagement. This initiative reflects the growing trend of utilizing chatbot technology in the healthcare sector to automate various tasks and improve the overall patient experience. Floatbot simplifies the often-lengthy process of scheduling appointments. Patients can quickly book their visits through the chatbot, reducing wait times and streamlining administrative workflows for the hospital.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global healthcare chatbots market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Component
• 3.2. Snippet by Deployment
• 3.3. Snippet by Application
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Demand for Virtual Health Assistance
  • 4.1.2. Restraints
    • 4.1.2.1. Data Privacy Concerns
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Component

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Component
  • 6.1.2. Market Attractiveness Index, By Component
• 6.2. Software*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Services

7. By Deployment

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
  • 7.1.2. Market Attractiveness Index, By Deployment
• 7.2. Cloud*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. On-Premise

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Symptom Checking*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Appointment Scheduling & Monitoring
• 8.4. Medical & Drug Information Assistance
• 8.5. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Patients*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Insurance companies
• 9.4. Healthcare providers
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Spain
    • 10.3.7.5. Italy
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Your.MD Ltd. *
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. HealthTap, Inc.
• 12.3. Sensely, Inc.
• 12.4. Buoy Health, Inc.
• 12.5. Infermedica
• 12.6. Ada Health GmbH
• 12.7. PACT Care BV.
• 12.8. Woebot Health
• 12.9. GYANT
• 12.10. Kenyt Inc.

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us